Advocating for a world where intellectual
property law serves the public interest.
The Multilateral Matters is an occasional blog on international developments related to intellectual property, innovation, development and public policy. Multilateral institutions matter because that is where international rule-making takes place. And, multilateral institutions are useful, especially for smaller and less powerful developing countries, because they are rules-based and every state, no matter its size, has a voice. However, in reality,
PIJIP has researched IP and trade for a while, but we’ve mostly focused on FTAs that included the US. This year we’ve begun to broaden our view – to look more closely at agreements like RCEP and other Asia-Pacific agreements. This fall we began a detailed comparison of CPTPP, RCEP, CETA, RCEP, EU-Mercosur, EU-Japan, and the China-Korea FTA, with a
[Communia Association] Last month the notorious EU Parliament vote approved almost all of the worst measures of the proposed Directive on Copyright in the Digital Single Market. It was a significant setback for user rights and the open internet. ...After the plenary vote in the Parliament on 12th September, the Directive moves into trilogue negotiations consisting of the Commission, Parliament,
[Miriam Marcowitz-Bitton, Yotam Kaplan and Maayan Perel (Filmar)] ... by any standard our patent system is broken. At present it encourages the filing of a plethora of low-quality patents that have no true innovative value, is plagued by opportunistic patent trolls, and produces endless amounts of costly litigation. This article demonstrates how these phenomena are due to central design flaws
[Gerald Leitner] IFLA specifically expresses support for the following points: A) Maintain the fair dealing exception for education... B) Retain the current copyright term of 50 years... C) Protect copyright exceptions from contract override and allow the circumvention of technological protection measures for non-infringing purposes... D) Provide clarity on the legal status of text and data mining (TDM)... E) Ensure
[Third World Network] In this paper Dr. Sengupta examines the landscape of biological medicines, and locates this analysis in the characteristics of biological drugs which set them apart from small molecule drugs (SMDs). These characteristics of biological drugs impact on the way these drugs are manufactured; on the development of follow-on versions of innovator biological drugs; on the way biological
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources